Search result

Phantom 4 RTK/feed/category/dji-mavic-3t-pl- Page 132

Woolworths share price barely budges after $300m property sale report — what ASX:WOW investors watch next

Woolworths share price barely budges after $300m property sale report — what ASX:WOW investors watch next

Woolworths shares slipped 0.1% to A$30.91 after reports of a possible A$300 million sale of shopping-centre assets to Forest Endeavour, linked to Shayher Group. The S&P/ASX 200 fell 1% as investors awaited Tuesday’s Reserve Bank of Australia decision. Woolworths is reviewing which assets could be sold over the next year. The company reports earnings Feb. 25.
2 lutego 2026
British American Tobacco share price ticks up on fresh buyback notice as dividend, Feb 12 results near

British American Tobacco share price ticks up on fresh buyback notice as dividend, Feb 12 results near

British American Tobacco shares rose 0.6% to 4,459 pence in early London trading after the company bought back 108,725 shares on Feb. 2, to be cancelled. BAT will pay its next dividend on Feb. 4 and release preliminary 2025 results on Feb. 12. The latest buyback reduced the share count to 2,176,779,980. Previous session volume was about 5.4 million shares.
3 lutego 2026
Verizon stock price dips in premarket as insider sale notice lands and analysts lift targets

Verizon stock price dips in premarket as insider sale notice lands and analysts lift targets

Verizon shares dipped 0.5% to $44.38 in premarket trading Tuesday after a Form 144 filing revealed an intended insider sale of 9,580 shares valued at about $430,000. Analysts cited churn rates, spending cuts, and competition as key concerns. Bernstein and TD Cowen raised price targets, while AT&T closed a $5.75 billion fiber deal with Lumen. The January jobs report was delayed due to a partial government shutdown.
Constellation Software’s 48% slide has investors split as AI fears rattle software stocks

Constellation Software’s 48% slide has investors split as AI fears rattle software stocks

Constellation Software shares have fallen about 48% in the past year amid investor concerns over AI’s impact on software pricing and a CEO transition. Founder Mark Leonard stepped down for health reasons, with Mark Miller now president. Ruane Cunniff says the stock trades at a high-teens forward P/E and sees the valuation as compelling despite ongoing uncertainty.
Taseko Mines (TGB) stock price jumps 13% as copper rebounds and insider sales hit the tape

Taseko Mines (TGB) stock price jumps 13% as copper rebounds and insider sales hit the tape

Taseko Mines shares rose 12.7% to $8.69 in NYSE American trading Tuesday, tracking a rebound in copper prices and metals stocks. Copper futures climbed nearly 4% after reports China may boost stockpiles. Insider filings showed executives and a director exercised and sold options totaling 200,000 shares at prices between C$10.50 and C$11.76. Trading volume reached about 10.4 million shares.
Pfizer (PFE) stock price slips before the bell after obesity-drug update, 2026 outlook

Pfizer (PFE) stock price slips before the bell after obesity-drug update, 2026 outlook

Pfizer shares fell 3.4% to $25.77 in Wednesday’s premarket after Novo Nordisk warned of lower 2026 sales and price pressure in obesity drugs. Pfizer’s GLP-1 trial met its main goal, showing up to 12.3% mean weight loss at 28 weeks, but safety questions remain. The company reaffirmed 2026 guidance and reported $17.6 billion in Q4 revenue. Investors await more VESPER-3 data at the June 6 ADA meeting.
Constellation Software hits a 1-year low — why analysts still see upside in CSU

Constellation Software hits a 1-year low — why analysts still see upside in CSU

Constellation Software shares hovered near a 52-week low Wednesday on the Toronto Stock Exchange, trading around C$2,342 after a steep two-day drop. Several banks cut price targets, but analysts tracked by MarketBeat kept a “moderate buy” consensus. The Sequoia Fund called the valuation “compelling” in a shareholder letter. Leadership changes continue after founder Mark Leonard stepped down last September.
4 lutego 2026
Reynolds Consumer Products stock jumps nearly 15% after Q4 results, steady 2026 outlook

Reynolds Consumer Products stock jumps nearly 15% after Q4 results, steady 2026 outlook

Reynolds Consumer Products shares jumped 14.6% to $25.00 after its Q4 earnings and 2026 outlook. The company reported Q4 net revenues of $1.034 billion and projected 2026 adjusted EBITDA of $660–$675 million, with EPS of $1.57–$1.63. The board approved a $0.23 dividend, payable Feb. 27. Retail revenues slipped, but non-retail sales rose sharply on higher aluminum demand.
Pfizer stock jumps nearly 4% — what’s driving PFE after the obesity-drug data drop

Pfizer stock jumps nearly 4% — what’s driving PFE after the obesity-drug data drop

Pfizer shares rose 3.9% to $26.78 before holding steady after hours, following new data on its obesity drug PF-3944 and quarterly results. The company maintained its 2026 revenue and earnings outlook but warned of pricing pressures and upcoming patent expirations. Mid-stage trial data showed up to 12.3% weight loss at 28 weeks, with some patients dropping out due to side effects. Trading volume topped 80 million shares.
5 lutego 2026
Cardinal Health stock jumps 9% after earnings beat — what CAH investors watch next

Cardinal Health stock jumps 9% after earnings beat — what CAH investors watch next

Cardinal Health shares jumped 9% to $226.05 Thursday after the company raised its fiscal 2026 adjusted earnings forecast to $10.15-$10.35 per share. Quarterly revenue rose 19% and adjusted profit beat estimates, driven by strong specialty drug demand. CEO Jason Hollar cited double-digit profit growth across all segments. Specialty medicines, including GLP-1 drugs, contributed significantly to revenue gains.
Pfizer stock price edges higher as Wall Street sizes up obesity-shot data and 2026 outlook

Pfizer stock price edges higher as Wall Street sizes up obesity-shot data and 2026 outlook

Pfizer shares rose 0.8% to $27.01 by early afternoon after the company reported up to 12.3% placebo-adjusted weight loss in a Phase 2b trial of its experimental obesity drug. Investors remain cautious amid concerns over patient dropout rates and side effects. Pfizer reaffirmed its 2026 forecast, projecting $59.5–$62.5 billion in revenue and $2.80–$3.00 adjusted earnings per share.
Tesla stock slides as Volkswagen tops Europe EV sales — what investors are watching next

Tesla stock slides as Volkswagen tops Europe EV sales — what investors are watching next

Tesla shares fell 2.7% to $394.85 after new data showed Volkswagen overtook Tesla in 2025 European battery-electric vehicle sales. January UK sales for Tesla plunged 57% year-on-year, while BYD and Ford gained ground. In China, Tesla’s market share slipped to 8% in 2025. A California judge signaled Tesla and CEO Elon Musk likely won’t get a copyright lawsuit dismissed.
1 130 131 132 133 134 171
Go toTop